CrushSCI.com
68.3平均天数
75中位天数
34最短天数
91最长天数
02025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

47 天

LINC00460 contributes to colorectal cancer cell invasion

作者
Weiguo Ren; Xuexiu Zhang; Qiang Li; Chibin Pu展开收起
作者单位
1. Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 2. Department of Oncology, Shenzhen Hospital, Southern Medical University, Zhengzhou, China; 3. Department of Gastroenterology, Zhongda Hospital, Southeast University, Nanjing, China展开收起
PDF源文件 DOI 网页
64 天

Application of blood purification technology in severe fever with thrombocytopenia syndrome

作者
Hongxia Gao; Baoyin Wang; Hui Yao; Wenjie Zhang; HaiFeng Teng展开收起
作者单位
1. Shandong University展开收起
PDF源文件 DOI 网页
34 天

CDCA7 serves as a novel prognostic marker in human hepatocellular carcinoma

作者
Yuan Tian; Wenwen Han; Long Fu; Kaiji Lv; Shugeng Wu展开收起
作者单位
1. Department of General Surgery, Ningbo Medical Center Lihuili Hospital, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, China; 2. Emergency Department, Ningbo Medical Center Lihuili Hospital, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, China展开收起
PDF源文件 DOI 网页
88 天

Effect of interventional embolization based on absolute ethanol for peripheral arteriovenous malformations

作者
Yanlin Wang; Dakan Liu; Li Xiao; Song Zuo; Tengfei Ren; Changxian Dong; Tianxiao Li展开收起
作者单位
1. Department of Hemangioma and Vascular Malformation, Zhengzhou University People’s Hospital; Henan Provincial People’s Hospital, Zhengzhou, China; 2. Department of Cerebrovascular Disease, Zhengzhou University People’s Hospital, Henan Provincial People's Hospital, Zhengzhou, China; 3. Henan Provincial NeuroInterventional Engineering Research Center, Henan International Joint Laboratory of Cerebrovascular Disease, and Henan Engineering Research Center of Cerebrovascular Intervention Innovation, Zhengzhou, China展开收起
PDF源文件 DOI 网页
89 天

Effect and imaging analysis of cetuximab combined with radiotherapy in patients with rectal carcinoma

作者
Shuai Zhang; Liangliang Liu; Shuguang Li; Xin Sun展开收起
作者单位
1. Gastrointestinal Cancer Surgery, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei, China; 2. Department of Pharmacy, Hebei North University, Zhangjiakou, Hebei, China; 3. Department of Imaging, The Fourth People’s Hospital of Jinan, Jinan, Shandong, China展开收起
PDF源文件 DOI 网页
91 天

A Prospective and Randomized Control Study on Effects of Thymalfasin for Injection on Perioperative Immune Function and Long-term Prognosis of Patients with Colorectal Cancer

作者
Wenbo Niu; Zhiying Li; Zhihan Li; Xuhua Hu; Xiaoran Wang; Yuanyi Ding; Chenhui Li; Bin Yu展开收起
作者单位
1. Surgery II, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, China; 2. Cadre ward, The 980th Hospital of the joint logistics support force of the PLA, Shijiazhuang City, Hebei Province, China展开收起
PDF源文件 DOI 网页

FAQ

Biotechnology and Genetic Engineering Reviews审稿要多久?

出版社标明该刊已于2024年停刊。此页保留历史论文及审稿记录。以下审稿周期来自该刊历史论文。截至2026-11-19,CrushSCI 收录了 Biotechnology and Genetic Engineering Reviews 的 10 篇完整审稿记录。最快一篇从收稿到录用用了 34 天(CDCA7 serves as a novel prognostic marker in human hepatocellular carcinoma,2023-04-11 收稿,2023-05-15 录用),最慢一篇用了 91 天;平均 68.3 天,中位数 75 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。